tiprankstipranks

Punit Dhillon Insider Profile

4 Followers
Punit Dhillon, CEO, Director at Skye Bioscience, holds 1.43M shares in Skye Bioscience (Ticker: SKYE), holds ― shares in Arch Therapeutics (Ticker: ARTHQ), holds 485.26K shares in OncoSec Medical (Ticker: ONCSQ).
tipranks
Punit Dhillon

Punit Dhillon
Skye Bioscience (SKYE)
CEO, Director

Ranked #15,426 out of 108,921 Corporate Insiders

Profitable Transactions

50%
3 out of 6 Profitable Transactions

Average Return

+22.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
99.99%
<0.01%
0.00%
A breakdown of Punit Dhillon's holdings

Insider Roles

Skye Bioscience
(SKYE)
CEO, Director
Inovio Pharmaceuticals
(INO)
VP, Finance & Operations
OncoSec Medical
(ONCSQ)
Director
Roles that Punit Dhillon holds in companies

Most Profitable Insider Trade

Stock:
Skye Bioscience
(SKYE)
Rating:Informative Buy
Date:Aug 11, 2020 - Aug 11, 2021
Return:+195.00%
The most profitable trade made by Punit Dhillon

Punit Dhillon's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Skye Bioscience
Aug 07, 2026
CEO, Director
Uninformative Buy
$2.66M
ARTHQ
Arch Therapeutics
OncoSec Medical
Jul 06, 2018
Director
Uninformative Buy
371.66K
Inovio Pharmaceuticals
VP, Finance & Operations
$264.55
List of latest transactions for each holding click on a transaction to see Punit Dhillon's performance on stock

Punit Dhillon insider profile FAQ

What is the percentage of profitable transactions made by Punit Dhillon?
The percentage of profitable transactions made by Punit Dhillon is 50%.
    What is the average return per transaction made by Punit Dhillon?
    The average return per transaction made by Punit Dhillon is 22.70%.
      What stocks does Punit Dhillon hold?
      Punit Dhillon holds: SKYE, ARTHQ, ONCSQ, INO stocks.
        What was Punit Dhillon’s latest transaction?
        Punit Dhillon latest transaction was an Uninformative Buy of ―.
          What was Punit Dhillon's most profitable transaction?
          Punit Dhillon’s most profitable transaction was an Informative Buy of SKYE stock on August 11, 2020. The return on the trade was 195.00%.
            What is Punit Dhillon's role in Skye Bioscience?
            Punit Dhillon's role in Skye Bioscience is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.